Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: Assessment of relapse during a 6-month, multisite, open-label study
Philip G. Janicak*, Ziad Nahas, Sarah H. Lisanby, H. Brent Solvason, Shirlene M. Sampson, William M. McDonald, Lauren B. Marangell, Peter Rosenquist, W. Vaughn McCall, James Kimball, John P. O'Reardon, Colleen Loo, Mustafa H. Husain, Andrew Krystal, William S Gilmer, Sheila M. Dowd, Mark A. Demitrack, Alan F. Schatzberg
Dive into the research topics of 'Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: Assessment of relapse during a 6-month, multisite, open-label study'. Together they form a unique fingerprint.